• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪酸合酶抑制剂奥利司他可减少 B16-F10 黑色素瘤的实验转移和血管生成。

The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.

机构信息

Department of Oral Diagnosis, School of Dentistry of Piracicaba, University of Campinas, Avenida Limeira 901, CP 52, Areão, Piracicaba, CEP 13414-018, SP, Brazil.

出版信息

Br J Cancer. 2012 Sep 4;107(6):977-87. doi: 10.1038/bjc.2012.355. Epub 2012 Aug 14.

DOI:10.1038/bjc.2012.355
PMID:22892389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3464771/
Abstract

BACKGROUND

Fatty acid synthase (FASN) is overexpressed and associated with poor prognosis in several human cancers. Here, we investigate the effect of FASN inhibitors on the metastatic spread and angiogenesis in experimental melanomas and cultured melanoma cells.

METHODS

The lung colonisation assay and cutaneous melanomas were performed by the inoculation of mouse melanoma B16-F10 cells in C57BL6 mice. Blood vessel endothelial cells (RAEC and HUVEC) were applied to determine cell proliferation, apoptosis, and the formation of capillary-like structures. Vascular endothelial growth factor A (VEGFA) expression was evaluated by quantitative RT-PCR and ELISA in B16-F10, human melanoma (SK-MEL-25), and human oral squamous carcinoma (SCC-9) cells. Conditioned media from these cancer cell lines were used to study the effects of FASN inhibitors on endothelial cells.

RESULTS

B16-F10 melanoma-induced metastases and angiogenesis were significantly reduced in orlistat-treated mice. Fatty acid synthase inhibitors reduced the viability, proliferation, and the formation of capillary-like structures by RAEC cells, as well as the tumour cell-mediated formation of HUVEC capillary-like structures. Cerulenin and orlistat stimulated the production of total VEGFA in B16-F10, SK-MEL-25, and SCC-9 cells. Both drugs also enhanced VEGFA(121), (165), (189,) and (165b) in SK-MEL-25 and SCC-9 cells.

CONCLUSION

FASN inhibitors reduce metastasis and tumour-induced angiogenesis in experimental melanomas, and differentially modulate VEGFA expression in B16-F10 cells.

摘要

背景

脂肪酸合酶(FASN)在多种人类癌症中过度表达,并与不良预后相关。在这里,我们研究了 FASN 抑制剂对实验性黑色素瘤和培养的黑色素瘤细胞转移和血管生成的影响。

方法

通过将小鼠黑色素瘤 B16-F10 细胞接种到 C57BL6 小鼠中进行肺定植实验和皮肤黑色素瘤实验。应用血管内皮细胞(RAEC 和 HUVEC)来确定细胞增殖、凋亡和毛细血管样结构的形成。通过定量 RT-PCR 和 ELISA 评估 B16-F10、人黑色素瘤(SK-MEL-25)和人口腔鳞状细胞癌(SCC-9)细胞中血管内皮生长因子 A(VEGFA)的表达。使用这些癌细胞系的条件培养基研究 FASN 抑制剂对内皮细胞的影响。

结果

在奥利司他治疗的小鼠中,B16-F10 黑色素瘤诱导的转移和血管生成显著减少。脂肪酸合酶抑制剂降低了 RAEC 细胞的活力、增殖和毛细血管样结构的形成,以及肿瘤细胞介导的 HUVEC 毛细血管样结构的形成。 cerulenin 和奥利司他刺激了 B16-F10、SK-MEL-25 和 SCC-9 细胞中总 VEGFA 的产生。这两种药物还增强了 SK-MEL-25 和 SCC-9 细胞中 VEGFA(121)、(165)、(189)和(165b)的表达。

结论

FASN 抑制剂可减少实验性黑色素瘤的转移和肿瘤诱导的血管生成,并在 B16-F10 细胞中差异调节 VEGFA 的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/232da6f5bdec/bjc2012355f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/22d83b087b6c/bjc2012355f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/76416ab82dca/bjc2012355f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/8856cdd8cad7/bjc2012355f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/ade504ae80e0/bjc2012355f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/3d9dfb6befb4/bjc2012355f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/232da6f5bdec/bjc2012355f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/22d83b087b6c/bjc2012355f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/76416ab82dca/bjc2012355f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/8856cdd8cad7/bjc2012355f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/ade504ae80e0/bjc2012355f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/3d9dfb6befb4/bjc2012355f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e9c3/3464771/232da6f5bdec/bjc2012355f6.jpg

相似文献

1
The fatty acid synthase inhibitor orlistat reduces experimental metastases and angiogenesis in B16-F10 melanomas.脂肪酸合酶抑制剂奥利司他可减少 B16-F10 黑色素瘤的实验转移和血管生成。
Br J Cancer. 2012 Sep 4;107(6):977-87. doi: 10.1038/bjc.2012.355. Epub 2012 Aug 14.
2
Effects of fatty acid synthase inhibitors on lymphatic vessels: an in vitro and in vivo study in a melanoma model.脂肪酸合酶抑制剂对淋巴管的影响:黑色素瘤模型的体外和体内研究
Lab Invest. 2017 Feb;97(2):194-206. doi: 10.1038/labinvest.2016.125. Epub 2016 Dec 5.
3
Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model.在小鼠黑色素瘤模型中,奥利司他抑制脂肪酸合酶可促进细胞凋亡并减少细胞生长和淋巴结转移。
Int J Cancer. 2008 Dec 1;123(11):2557-65. doi: 10.1002/ijc.23835.
4
Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.在黑色素瘤细胞中抑制脂肪酸合酶会激活细胞凋亡的内在途径。
Lab Invest. 2011 Feb;91(2):232-40. doi: 10.1038/labinvest.2010.157. Epub 2010 Aug 30.
5
The antimetastatic activity of orlistat is accompanied by an antitumoral immune response in mouse melanoma.奥利司他的抗转移活性伴随着小鼠黑色素瘤的抗肿瘤免疫反应。
Cancer Chemother Pharmacol. 2020 Feb;85(2):321-330. doi: 10.1007/s00280-019-04010-1. Epub 2019 Dec 20.
6
Fatty acid synthase inhibitors induce apoptosis in non-tumorigenic melan-a cells associated with inhibition of mitochondrial respiration.脂肪酸合酶抑制剂可诱导非致瘤性黑素-a细胞发生凋亡,这与线粒体呼吸的抑制相关。
PLoS One. 2014 Jun 25;9(6):e101060. doi: 10.1371/journal.pone.0101060. eCollection 2014.
7
Tumor growth retardation and chemosensitizing action of fatty acid synthase inhibitor orlistat on T cell lymphoma: implication of reconstituted tumor microenvironment and multidrug resistance phenotype.脂肪酸合酶抑制剂奥利司他对T细胞淋巴瘤的肿瘤生长抑制及化疗增敏作用:重构肿瘤微环境和多药耐药表型的影响
Biochim Biophys Acta. 2014 Jan;1840(1):294-302. doi: 10.1016/j.bbagen.2013.09.020. Epub 2013 Sep 20.
8
Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion.一种靶向辐射诱导侵袭的基质金属蛋白酶抑制剂对血管生成和肿瘤生长的抑制作用
Mol Cancer Ther. 2005 Nov;4(11):1717-28. doi: 10.1158/1535-7163.MCT-05-0179.
9
The fatty acid synthase inhibitor orlistat reduces the growth and metastasis of orthotopic tongue oral squamous cell carcinomas.脂肪酸合酶抑制剂奥利司他可降低原位舌口腔鳞状细胞癌的生长和转移。
Mol Cancer Ther. 2014 Mar;13(3):585-95. doi: 10.1158/1535-7163.MCT-12-1136. Epub 2013 Dec 20.
10
Fatty acid synthase inhibitor orlistat induces apoptosis in T cell lymphoma: role of cell survival regulatory molecules.脂肪酸合酶抑制剂奥利司他诱导T细胞淋巴瘤细胞凋亡:细胞存活调节分子的作用
Biochim Biophys Acta. 2012 Nov;1820(11):1764-73. doi: 10.1016/j.bbagen.2012.07.010. Epub 2012 Jul 31.

引用本文的文献

1
Endothelial SIRT3 deficiency predisposes brown adipose tissue to whitening in diet-induced obesity.内皮细胞SIRT3缺乏使棕色脂肪组织在饮食诱导的肥胖中易发生白化。
Int J Biol Sci. 2025 May 15;21(8):3444-3460. doi: 10.7150/ijbs.110741. eCollection 2025.
2
Orlistat facilitates immunotherapy via AKT-FOXO3a-FOXM1-mediated PD-L1 suppression.奥利司他通过AKT-FOXO3a-FOXM1介导的PD-L1抑制促进免疫治疗。
J Immunother Cancer. 2025 Mar 26;13(3):e008923. doi: 10.1136/jitc-2024-008923.
3
Altered fatty acid metabolism rewires cholangiocarcinoma stemness features.

本文引用的文献

1
VEGF₁₂₁b and VEGF₁₆₅b are weakly angiogenic isoforms of VEGF-A.VEGF₁₂₁b 和 VEGF₁₆₅b 是 VEGF-A 的弱血管生成异构体。
Mol Cancer. 2010 Dec 31;9:320. doi: 10.1186/1476-4598-9-320.
2
Inhibition of fatty acid synthase in melanoma cells activates the intrinsic pathway of apoptosis.在黑色素瘤细胞中抑制脂肪酸合酶会激活细胞凋亡的内在途径。
Lab Invest. 2011 Feb;91(2):232-40. doi: 10.1038/labinvest.2010.157. Epub 2010 Aug 30.
3
Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas.
脂肪酸代谢改变重塑胆管癌干性特征。
JHEP Rep. 2024 Aug 6;6(10):101182. doi: 10.1016/j.jhepr.2024.101182. eCollection 2024 Oct.
4
Elucidating the Role of Lipid-Metabolism-Related Signal Transduction and Inhibitors in Skin Cancer.阐明脂质代谢相关信号转导及其抑制剂在皮肤癌中的作用
Metabolites. 2024 May 28;14(6):309. doi: 10.3390/metabo14060309.
5
Metabolic Regulation of Endothelial Cells: A New Era for Treating Wet Age-Related Macular Degeneration.内皮细胞代谢调控:治疗湿性年龄相关性黄斑变性的新时代。
Int J Mol Sci. 2024 May 29;25(11):5926. doi: 10.3390/ijms25115926.
6
Fatty Acid Synthase as Interacting Anticancer Target of the Terpenoid Myrianthic Acid Disclosed by MS-Based Proteomics Approaches.基于 MS 蛋白质组学方法发现的三萜烯酸作为脂肪酸合酶相互作用的抗癌靶点。
Int J Mol Sci. 2024 May 29;25(11):5918. doi: 10.3390/ijms25115918.
7
Hepatocellular carcinoma patients serum modulates the regenerative capacities of adipose mesenchymal stromal cells.肝细胞癌患者血清调节脂肪间充质干细胞的再生能力。
Heliyon. 2024 Feb 1;10(3):e24794. doi: 10.1016/j.heliyon.2024.e24794. eCollection 2024 Feb 15.
8
LncRNA RPARP-AS1 promotes the progression of osteosarcoma cells through regulating lipid metabolism.长链非编码 RNA RPARP-AS1 通过调节脂质代谢促进骨肉瘤细胞的进展。
BMC Cancer. 2024 Feb 2;24(1):166. doi: 10.1186/s12885-024-11901-x.
9
Fatty acid synthase (FASN) signalome: A molecular guide for precision oncology.脂肪酸合酶(FASN)信号组学:精准肿瘤学的分子指南。
Mol Oncol. 2024 Mar;18(3):479-516. doi: 10.1002/1878-0261.13582. Epub 2024 Jan 18.
10
Orlistat exerts anti-obesity and anti-tumorigenic effects in a transgenic mouse model of endometrial cancer.奥利司他在子宫内膜癌转基因小鼠模型中发挥抗肥胖和抗肿瘤作用。
Front Oncol. 2023 Aug 4;13:1219923. doi: 10.3389/fonc.2023.1219923. eCollection 2023.
脂肪酸合酶的表达依赖于 NAC1 并与复发性卵巢浆液性癌相关。
J Oncol. 2010;2010:285191. doi: 10.1155/2010/285191. Epub 2010 May 19.
4
Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays.定量表达 VEGF、VEGF-R1、VEGF-R2 和 VEGF-R3 在黑色素瘤组织微阵列中的表达。
Hum Pathol. 2010 Mar;41(3):375-84. doi: 10.1016/j.humpath.2009.08.016. Epub 2009 Dec 11.
5
Serum fatty acid synthase as a marker of pancreatic neoplasia.血清脂肪酸合酶作为胰腺肿瘤的标志物。
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2380-5. doi: 10.1158/1055-9965.EPI-09-0144. Epub 2009 Sep 1.
6
Inhibition of fatty acid synthase by Orlistat accelerates gastric tumor cell apoptosis in culture and increases survival rates in gastric tumor bearing mice in vivo.奥利司他对脂肪酸合酶的抑制作用可加速体外培养的胃肿瘤细胞凋亡,并提高体内荷胃肿瘤小鼠的生存率。
Lipids. 2009 Jun;44(6):489-98. doi: 10.1007/s11745-009-3298-2. Epub 2009 Apr 21.
7
Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.泛素特异性蛋白酶 2a(USP2a)、脂肪酸合酶(FASN)和 ErbB2 表达在口腔鳞状细胞癌中的临床病理意义。
Oral Oncol. 2009 Oct;45(10):e134-9. doi: 10.1016/j.oraloncology.2009.02.004. Epub 2009 Apr 9.
8
Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer.脂肪酸合酶:一种代谢酶及前列腺癌中的候选癌基因。
J Natl Cancer Inst. 2009 Apr 1;101(7):519-32. doi: 10.1093/jnci/djp030. Epub 2009 Mar 24.
9
Cohort study of fatty acid synthase expression and patient survival in colon cancer.脂肪酸合酶表达与结肠癌患者生存率的队列研究。
J Clin Oncol. 2008 Dec 10;26(35):5713-20. doi: 10.1200/JCO.2008.18.2675. Epub 2008 Oct 27.
10
VEGF-A splicing: the key to anti-angiogenic therapeutics?血管内皮生长因子A剪接:抗血管生成疗法的关键?
Nat Rev Cancer. 2008 Nov;8(11):880-7. doi: 10.1038/nrc2505. Epub 2008 Oct 16.